New asthma treatment effective
This is a UK news story, published by ScienceDaily, that relates primarily to Benralizumab news.
UK news
For more UK news, you can click here:
more UK newsBenralizumab news
For more Benralizumab news, you can click here:
more Benralizumab newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsScienceDaily news
For more news from ScienceDaily, you can click here:
more news from ScienceDailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
asthma attack. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest severe asthma news, COPD exacerbations news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
asthma attacksScienceDaily
•First new treatment for asthma attacks in 50 years
72% Informative
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30% .
Benralizumab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung inflammation.
After 28 days , respiratory symptoms of cough, wheeze, breathlessness and sputum were found to be better with the injection.
COPD is the third leading cause of death worldwide but treatment for the condition is stuck in the 20th century .
The ABRA trial was only possible with collaboration between the NHS and universities.
Every four minutes in the UK , someone dies from a lung condition.
With your help, we're fighting for more life-changing, life-saving research to transform the future.
VR Score
80
Informative language
86
Neutral language
18
Article tone
formal
Language
English
Language complexity
55
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links